← Back
Data updated: Mar 10, 2026
SPRINGWORKS
OncologyGastroenterology
SPRINGWORKS is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include OGSIVEO.
2023
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Recent Activity
GOMEKLI 2025-02-11
Type 1 - New Molecular Entity
GOMEKLI 2025-02-11
Type 3 - New Dosage Form
OGSIVEO 2024-04-04
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 94%
1 drugs Phase 3: 1 Phase 2: 2 Phase 1: 3
Gastroenterology 6%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...